Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Open Access
- 1 May 1983
- Vol. 24 (5) , 418-420
- https://doi.org/10.1136/gut.24.5.418
Abstract
The prevalence of symptoms suggestive of a motility disturbance similar to the irritable bowel syndrome was investigated in 98 patients with ulcerative colitis in remission, and a similar number of age- and sex-matched healthy controls. Thirty-three per cent of patients compared with 7% of controls fulfilled the criteria for such a syndrome (p<0·01). Contrary to expectations these symptoms were not confined to patients with distal disease. Other symptoms such as constipation were also very common in the colitic group (31%).This publication has 21 references indexed in Scilit:
- Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer.Gut, 1982
- Healing of gastric ulcers after one, two, and three months of ranitidine.BMJ, 1982
- Symptom relief and the placebo effect in the trial of an anti-peptic drug.Gut, 1981
- Ranitidine in the Treatment of Duodenal UlcerationScandinavian Journal of Gastroenterology, 1981
- Cimetidine and ranitidine in duodenal ulcer.BMJ, 1980
- Cimetidine in the prevention of gastric ulcer relapsePublished by Oxford University Press (OUP) ,1979
- Prophylactic Effect of Cimetidine in Gastric Ulcer PatientsScandinavian Journal of Gastroenterology, 1979
- INHIBITION OF PENTAGASTRIN-STIMULATED AND NOCTURNAL GASTRIC SECRETION BY RANITIDINEThe Lancet, 1979
- GASTRIC INHIBITORY ACTION OF H2-ANTAGONISTS RANITIDINE AND CIMETIDINEThe Lancet, 1979
- Prophylaxis with deglycyrrhizinised liquorice in patients with healed gastric ulcer.BMJ, 1978